AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| TTK Resignation of Chief Transformation Officer | |||
| 16/04/18 | |||
| TTK Appointment of Chief Technology Officer | |||
| 16/04/18 | |||
| TTK Change in Officers | |||
| 05/04/18 | |||
| TTK Retirement of Director: Geoff Davis | |||
| 03/04/18 | |||
| TTK TeamTalk 1H18 Interim Report | |||
| 27/03/18 | PRICE SENSITIVE | ||
| TTK D&O Ongoing Disclosure – David Struthers | |||
| 20/03/18 | |||
| TTK Ongoing Disclosure Notices - Multiple | |||
| 14/03/18 | |||
